In the last couple of decades, researchers have focused on finding strategies for the prevention of cognitive decline in the geriatric age group. Equivocal evidence is available from high-quality randomized controlled studies regarding causative role of modifiable midlife risk factors in cognitive decline and dementia. Among the cardiovascular risk factors, hypertension, hyperlipidemia, obesity, high saturated fat intake, and cigarette smoking have been found to be present in more than 50% of the cases of dementia and cognitive decline. Adopting healthy lifestyle changes with diet, regular moderate levels of physical activity, and abstinence from substance use have been found to have consistent evidence in the prevention of cognitive decline among other ambiguous findings across cultures. Studies assessing preventive and beneficial role of pharmacological treatment strategies such as preemptive use of disease modifying drugs, cerebroactive drugs, and nutritional supplements have been inconclusive. Psychological intervention strategies have shown some promising results. This review attempts to understand some of the perplexing issues in the prevention of cognitive decline in old age.
Introduction
Benjamin Franklin once said that "an ounce of prevention is worth a pound of cure." This wisdom has been applied in the field of medicine for more than two centuries and perhaps may lead to foundation of preventive medicine as the world knows today. The scientific aspects of prevention are relevant at all stages of life beginning from the intrauterine phase to old age. The preventive approaches have been applied and practiced in medicine with the goal of improving the quality of life.
Old age differs from other age groups in having higher morbidity related to degenerative disorders, multiple and complex medical and psychiatric comorbidities, disability, and care issues with inadequate financial and social support systems. [1] These factors account for a higher disease burden increasing the health and societal cost of care. This has made preventive medicine and psychiatry all the more relevant for a healthier and a resourceful old age.
Several studies have been conducted in the last two decades to understand the risk and protective factors in aging and dementia. In the Indian context, hospital and with the advent of functional neuroimaging techniques, this claim was refuted but sowed the seeds of the concept of "Reserve Brain Capacity" and "Cognitive Reserve." Accordingly, interindividual variation exists in clinical presentation given the same extent of brain damage.
Brain reserve capacity (BRC) (or threshold model/passive model or the "hardware") comprises the brain size, neuronal count, and the synaptic density which is a fixed quantitative measure and damage to the brain impairing the BRC beyond a certain threshold value is likely to produce clinically significant symptoms. Higher the BRC, more is the capacity of the brain to bear insult and lesser are the chances of developing clinically relevant neurological deficits. On the other hand, cognitive reserve (active model/the "software") reflects the brain's coping with injury using preexisting cognitive processes to increase the efficiency and capacity of existing neural pathways (also called neural reserve) or using compensatory processes to recruit new pathways that lie dormant (also called neural compensation). Various factors have been found to determine the extent of Cognitive Reserve such as lifestyle, cognitively stimulating activities, level of education, leisure activities, social stimulation, sleep, diet, and physical activities in early life. [6, 7] Current evidence suggests modulation of these factors in a positive way to prevent cognitive decline in the elderly population. In landmark study, [8] sister Mary, one of the 678 participants of the Nun study, who had widespread classical neuropathological lesions of Alzheimer's disease but yet never developed cognitive decline; and went on to live till 101 years remains the gold standard human brain specimen that exemplifies that cognitive impairment is not an inevitable consequence of aging and dementia and that a positive outlook toward life can prevent cognitive decline. This article attempts to review the current scientific evidence available for common risk factors and preventive measures to slow progression of cognitive decline in the geriatric population.
Modifiable Medical Risk Factors

Hypertension
Hypertension has been the most common cardiovascular risk factor to be studied in dementia and cognitive decline. Midlife hypertension is a well-established risk factor for developing dementia in later life, [9] but the reports regarding late-life hypertension were conflicting. The earliest study by Skoog et al., [10] to establish a causal link between late-life hypertension and dementia, was conducted in 382 nondemented community-dwelling elderly persons (above 70 years) over a period of 15 years. Participants who developed dementia at the age of 79-85 years had an increased systolic blood pressure at 70 years (178 vs. 164 mm Hg, P = 0.034) and an elevated diastolic blood pressure at 70 years (101 vs. 92 mm Hg, P = 0.004) than those who did not develop dementia. Cochrane database review has also yielded a consistent relationship between high blood pressure and cognitive decline but not with dementia. [11, 12] Few studies in India have been conducted that have found hypertension along with diabetes and smoking as risk factors for mild cognitive impairment. [13] Hypertension has also been associated with progression of dementia in one-third of the elderly population who exhibit executive-function deficits. [14] Earlier studies have also documented late-life hypertension to be having a protective effect against cognitive decline. The reason being that in long-standing hypertension, secondary atherosclerotic changes ensue decreasing cerebral perfusion and in such patients, late-life hypotension is more detrimental than hypertension in causing cognitive decline. [15] In the background of substantial evidence toward hypertension causing progression of cognitive decline in the elderly, evidence toward antihypertensive treatment being beneficial or not is still controversial. The findings of available high-quality randomized controlled trials for the use of antihypertensives for prevention of cognitive decline continues to be uncertain. However, this should not influence clinicians to initiate treatment in high-risk cases. [16] Hyperlipidemia Very few high-quality cohort studies have assessed the association of hyperlipidemia and cognitive decline and dementia. According to the survivors of the Finnish cohorts of the seven countries study, a population-based sample of 444 men aged 70-89 years, a previous high serum cholesterol level (mean >6.5 mmol/L) was a significant predictor of the prevalence of Alzheimer's dementia with an odds ratio of 3.1 (95% confidence interval [CI] 1.2-8.5) after controlling for age, apolipoprotein-E and genotype. [17] In another longitudinal follow-up study of 21 years involving 1449 individuals aged 65-79 years, the relationship between serum total cholesterol and dementia seemed bidirectional, i.e. elevated serum total cholesterol in midlife predicted dementia; however, a moderate reduction (0.5-2 mmol/L) in serum total cholesterol in midlife was a risk factor for late-life cognitive impairment. [18] In a similar study, a raised systolic blood pressure (>160 mm Hg) or an elevated serum total cholesterol (>6.5 mmol/L) both predicted late-life Alzheimer's dementia and a higher odds ratios when both were present together. [19] The use of statins for managing dyslipidemia in dementia patients has been surrounded by controversy. Some studies have clearly documented the role of statins in reducing the risk of dementia, but most studies including Cochrane database systematic reviews have found inconsistent evidence to support the use of statins. [20, 21] However, in spite of the myriad studies often with contradictory findings, their use is recommended in high-risk cases.
Type-2 diabetes mellitus
There is enough evidence to establish that Type-2 diabetes mellitus (T2DM) is associated with vascular pathology and thereby vascular dementia. Research has also found associations between diabetes mellitus and Alzheimer's dementia. Preventing microvascular and macrovascular complications in diabetes have been the focus of intervention strategies overlooking cognitive dysfunction, and much research is needed in this area. Self-care behavior, monitoring, and sensing derangements in sugar levels depend on the cognitive capacity which itself can be impaired by the degenerative process, thereby, creating a precarious clinical situation. [22] The earliest reports of association of T2DM with increased risk of dementia came from the Rotterdam study [23] following which other studies have come out with similar findings. The Honolulu-Asia Ageing study [24] assessed 3734 Japanese-American men above 70 years of age and found that the relative risk for Alzheimer's dementia in diabetics was 1.8 (95% CI 1.1-2.9) and that of vascular dementia in diabetics was 2.3 (95% CI 1.1-5.0). The relative risk for developing dementia was higher in diabetic patients with APOE4 allele. Multiple mechanisms, ranging from insulin resistance, increased permeability and inflammation of the blood-brain barrier, decreased neurogenesis in the hippocampus, have been postulated, but the exact mechanism for cognitive dysfunction in diabetes has not been elucidated. [22] Researchers have concluded that patients with mild cognitive impairment and diabetes are more likely to progress to dementia than those without diabetes, [22, [25] [26] [27] and hence, clinician's approach is targeted toward preventing hyperglycemia and rapid fluctuations in sugar levels. However, the best possible strategy for hyperglycemia reduction [22, 28] and pharmacological combination strategy among antidiabetic drugs available in the market requires systematic research.
Midlife obesity
The human race has slowly moved from its nomadic existence, engaging in hunting and foraging, to an urban living with less physical activity and readily available frozen and fast foods. This has led to an epidemic of obesity in early childhood and adulthood. It would take many years to fully understand the impact of obesity on various life parameters in totality.
There is preliminary evidence to suggest that midlife obesity does have an impact on cognitive decline and dementia among other disorders. A body mass index (>30) has been found to be a significant risk factor for dementia with an odds ratio of 2.4 in properly matched samples. The most astounding fact is that changes in dietary habits and fat reduction do not lower the risk of developing dementia. [29] Most studies postulate an association between midlife obesity and risk of dementia, [30] [31] [32] but alarmingly, contrary evidence to the same also does exist. According to a retrospective cohort study of 2 million people over two decades, being underweight in mid and late life was a risk factor for dementia. [33] 
Subclinical thyroid dysfunction
The evidence that subclinical thyroid dysfunction increasing the risk of dementia and cognitive decline came originally from the Rotterdam study. [34] Subsequent studies which had a small sample size and of short duration were inconclusive. It is believed that the effects on cognitive decline in thyroid dysfunction are secondary to the cardiovascular complications such as hypertension, dyslipidemia in hypothyroidism, and atrial fibrillation in hyperthyroidism. In the largest longitudinal study, prospective study of pravastatin in the elderly at risk study with 5154 participants, no association was found between subclinical thyroid dysfunction and cognitive decline. The current available evidence does not support the treatment of subclinical thyroid dysfunction, but only a large, randomized controlled trial can provide a clearer picture. [35] 
Lifestyle Risk Factors for Cognitive Decline
Smoking
Smoking and cognitive decline have been a much-researched subject. By and large, there is a consensus across various prospective studies, systematic reviews, and meta-analyses that smoking is a major risk factor for dementia. In a multiethnic population study with a follow-up of 23 years, involving 21,123 individuals, one-fourth of subjects were diagnosed with dementia. Of these patients, active smokers had 2.57 times higher risk of developing Alzheimer's dementia and 2.72 times more risk of developing vascular dementia. [36] Systematic reviews of prospective studies have shown a strong evidence for the risk of cognitive decline in smokers [37, 38] and the risk decreases after the cessation of smoking. [39] 
Alcohol consumption and cognition
Alcohol is well known to have long-term neurological adverse effects, including its effect on cognition. The hallmark of alcohol-induced amnestic disorder is a short-term memory loss caused by long-term alcohol use and is distinguishable from alcohol-induced persisting dementia, wherein patients have a global cognitive decline. However, recent studies have documented a protective effect of small to moderate drinking on cognitive decline. In a 15 years prospective follow-up study, comprising 11,000 US nurses with alcohol consumption between 1-14.9 g/day, alcohol led to reduction in cognitive decline with a relative risk of 0.85 in comparison to those who were abstinent. [40] The study received much criticism in being an observational study wherein interviews were conducted on telephone, with no adjustment for social or health characteristics. [41] Alcohol use and its cognitive impact in late life have been less researched chiefly because of the ethical and logistic difficulties of organizing such a study in old age. A meta-analysis of 23 longitudinal studies on elderly revealed a protective effect of alcohol on cognitive decline. [42] In 3 years longitudinal follow-up study, comprising 3202 adults above 75 years who were cognitively intact at study inclusion, 217 individuals (6.7%) developed dementia. Irrespective of the type or quantity of alcohol consumed small-to-moderate doses of alcohol were found to have a protective effect and reduced the incidence of dementia in the elderly population. [43] Various reasons have been stated for the protective role of alcohol on cognitions ranging from improvement in HDL levels to the rheogenic effects of alcohol on blood. Applying this knowledge to practice and advising individuals for small-to-moderate levels of alcohol consumption is neither practical nor safe because of other risks involved with alcohol consumption, especially damage to other organs of the body and falls during intoxication.
Physical activity
The first meta-analysis to testify a significant protection from cognitive decline by performing regular physical activities included 15 prospective studies, with a mean follow-up of 5 years. All the 33,816 individuals were cognitively intact at study inclusion and above 65 years. The result showed that high physical activity reduced cognitive decline by 38% and moderate level of activity reduced cognitive decline by 35%. [44] Subsequently, most of the prospective studies, systematic reviews, and meta-analyses have consistently documented the protective effects of mild-to-moderate levels of physical activity such as walking but no optimal duration or span during which the activity be continued has been documented. [39] Diet Food fads vary across individuals and cultures. Given different compositions of nutrients, vitamins, and minerals in diets make such studies and its results difficult to interpret. Nevertheless, many controlled studies have documented a relationship between diet and cognitive decline. A diet high in saturated fats was associated with poor cognitive functions than a diet rich in monounsaturated fatty acids. [45] Most of the researchers conclude in recommending a diet rich in Omega-3 fatty acids (plentiful in fish), folates, and vitamins, especially vitamin B, C, and E for neuroprotective effects in dementia. The earliest evidence for Omega 3 fatty acids emerged from a prospective sample of the Rotterdam study, [46] which included 5386 nondemented persons aged 55 years and above. The relative risk was found to be 0.4 (below 1) implying a protective role for fish consumption in preventing cognitive decline. In the Chicago Health and Ageing Project, [47] a 6-year prospective study with 6158 residents with age >65 years; consuming one fish meal per week had a 10% slower cognitive decline measured in standardized units and those consuming >2 fish meals per week had a 13% slower cognitive decline with age.
Another finding that has been consistent across different researches is the neuroprotective role of a Mediterranean diet, which includes little red meat, whole grains, fruits, vegetables, fish, nuts, olive oil, and red wine. At least, seven longitudinal studies (published between 2008 and 2010) focused on links between a Mediterranean diet and risk reduction of neurodegenerative diseases in the elderly population. [48] Often in clinical practice, antioxidant nutritional supplements are prescribed by doctors in the elderly population. Very few longitudinal cohort studies have examined the effectiveness of antioxidant nutritional supplements (Vitamin A, C, E, Beta-carotene, Zinc, and Selenium) and one such study is the Monongahela Valley Independent Elders Survey Project, in which no significant difference was found in cognitive test performances between antioxidant nutritional supplement users and nonusers. [49] The current available evidence does not support the use of these nutritional antioxidant supplements for improving cognition.
Perhaps, the best possible evidence is in support of what has been called as the memory preservation diet which includes a diet rich in Omega-3 fatty acids, folates, and Vitamin B, C, and E, prevention or reduction of insulin resistance, and prevention of inflammation along with blueberries which possibly has a synergistic contributions in brain cell health. [50] Depression Depression in context of dementia has a special significance since it influences the illness characteristics, diagnosis, subsequent treatment given, illness outcome, and the overall burden of care. [51, 52] It has also been proposed that depression in dementia may be the consequence of ongoing neurodegeneration, possibly due to underlying vascular pathology like stroke. [53] There are several common risk factors exist for depression and dementia, [51, 54] which suggests the common neurobiological mechanisms of genesis of depression and dementia. Identification and appropriate intervention for the management of depression in elderly help in prolonging the life, minimizing the sufferings, and reducing the burden of care associated with cognitive decline.
Pharmacological Interventions in Preventing Cognitive Decline
Hormone replacement therapy
Epidemiological studies on postmenopausal elderly women have shown positive results in preventing cognitive decline in that receiving hormone replacement therapy (HRT) over a 3 years period. [55] However, randomized controlled trials of short-term estrogen therapy for elderly women with Alzheimer's disease did not improve cognitive symptoms. [56, 57] In another study, the risk of use of estrogen plus progesterone outweighed the benefits by increasing the risk of dementia in postmenopausal women. [58] Hence, by and large, HRT is not recommended as a preventive strategy for cognitive decline in the elderly population.
Use of cerebro-active drugs
Ginkgo biloba extracted from the Ginkgo tree, indigenous to China and the only living species of Ginkophyta, with the rest being extinct originally showed promising results in improving cognitive function in the elderly. However, randomized controlled trials, systematic reviews, and meta-analysis have failed to show any conclusive results or benefits in improving the activities of daily living in probable or potential dementia patients. Similarly, other medicinal extracts such as ginseng have also failed to show any beneficial effect. [59] [60] [61] [62] There is not enough evidence to support the use of disease-modifying drugs (Rivastigmine or Memantine etc.,) in mild cognitive impairment and early stages of dementia. [63] 
Psychological Interventions in Prevention of Cognitive Decline
Primarily, there are three cognitive interventions [64] which have substantial evidence for efficacy in cognitive decline and dementia: a. Cognitive training which involves the use of computer-based or paper-pencil exercises. It can be delivered in a group setting or on an individual basis. It is useful in targeting specific deficits such as memory deficits in the elderly, learning compensatory techniques, and improving skills b. Cognitive stimulation therapy involves stimulating the brain with different enjoyable activities and is mostly done in a group setup. Although it is known to be efficacious evidence to support, the same is confounded by the fact that it is provided in a social setup and that itself may be a reason for change c. Cognitive rehabilitation aims to identify and work on personally relevant difficulties and goals. Difficulties in memory and patient's activities of daily living can be addressed through it.
A recent Cochrane review found 36 randomized controlled trials of cognitive training interventions which showed evidence of improvement in immediate and delayed recalls among the treatment group, but yet other systematic reviews and meta-analysis showed inconclusive results. [39] 
Occupational Therapy Interventions
In very early stages of dementia, occupational therapy intervention can enhance their adaptability to a new environment, increase their independence in their skilled tasks, and improve the overall quality of life of such persons. The basic strategies adopted in occupational therapy include the assessment of the difficulties of the person, breaking the task into easy, small and understandable steps as in early stages attention, and concentration difficulties are common. Patients are first made competent in establishing their activities of daily living such as bathing, washing, wearing clothes, eating, and structuring their daily routine. In case, the person has difficulty remembering, an aid such as a diary or a smartphone alarm may be used to assist the person. Attempts to understand difficulties in communication with others and problems in social engagement can be addressed by involving the person in group activities on outpatient basis. Some patients with dementia have fear of fall, and occupational therapy intervention can help prevent falls in the elderly, thereby preventing disability due to injuries.
The goal of occupational therapy is to achieve mastery over basic and specific skills for daily living and go a long way in prevention, especially in the absence of no effective pharmacological strategies in the prevention of cognitive decline. [65] There is a lack of systematic studies that assess occupational therapy interventions in preventing cognitive decline and need to be done in the future.
Other Factors Associated with Cognitive Decline
Earlier studies have hinted toward higher education level to be protective for cognitive decline compared to no formal education at all. Autopsy studies done on patients with dementia have shown that higher education does not modify the course of Alzheimer's disease, but in patients with lower education level, there are more neuropathological lesions. Traumatic brain injuries increase the risk of dementing illness and so does a history of depression and sleep disorders. Age, familial aggregation, and genetic susceptibility genes such as APOE4 are unmodifiable risk factors. [28, 52, 54] 
Conclusion
With the huge aging population worldwide, there have been genuine and valid concerns to find out strategies to prevent the 'march' of cognitive decline toward dementia. [66] Midlife risk factors such as arterial hypertension, hypercholesterolemia, obesity, high saturated fat intake, and cigarette smoking are important risk factors for cognitive decline. Reducing these risk factors by adopting health lifestyle strategies, healthy diet, and abstinence from substance use can reduce the overall cases of dementia and cognitive decline significantly.
Although pharmacological strategies have not shown any positive outcomes in high-quality randomized controlled studies at the same, they have also not shown negative outcomes to deter physicians from using them in moderate-to-high risk cases. The most promising results are emerging from nonpharmacological preventive strategies such as lifestyle modulation, including physical exercise, healthy diet and cognitive training and individual and group occupational therapy interventions but long-term, multicentric longitudinal randomized controlled trial's need to be conducted in this domain to astutely document their efficacy.
While research takes its own course in enlightening humanity about preventive strategies for cognitive decline, one can take inspiration from the famous Sister Mary of the Nun study. If one delves into the life of Sister Mary, one would learn of her analytical, practical, simplistic, positive, and undying attitude toward life that kept her physically and mentally fit till the end. Perhaps, this can be the guiding light for the aging mankind and save itself from drowning in the abyss and darkness of aging making it rich and resourceful.
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